Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Molecules (Basel, Switzerland)|September 9, 2022
Radionuclides for Targeted Therapy: Physical PropertiesCaroline Stokke, Monika Kvassheim, Johan BlakkisrudEJNMMI Physics|August 4, 2022
Quantitative SPECT/CT imaging of lead-212: a phantom studyMonika Kvassheim, Mona-Elisabeth R Revheim, Caroline StokkeJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2023
Optimized SPECT Imaging ofLars Tore Gyland Mikalsen, Monika Kvassheim, Caroline StokkeEJNMMI Physics|January 6, 2026
Assessing the feasibility of quantitative SPECT imaging for low 212Pb activity concentrations using anthropomorphic phantomsJohan Høiness, Caroline Stokke, Eivor Hernes, et al.Physics in Medicine and Biology|November 13, 2024
Twisted clustered pinhole collimation for improved high-energy preclinical SPECT/PETValerio Cosmi, Monika Kvassheim, Satyajit Ghosh, et al.EJNMMI Physics|August 21, 2023
Imaging of 212Pb in mice with a clinical SPECT/CTMonika Kvassheim, Anna Julie Kjøl Tornes, Asta Juzeniene, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2025
Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancerAnna Julie Kjøl Høyvik, Monika Kvassheim, Li-Wei Ma, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2026
Normal Tissue Dosimetry of Intraperitoneal 224Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal MetastasesSimen Rykkje Grønningsæter, Johan Blakkisrud, Monika Kvassheim, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2025
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate CancerKjetil Berner, Eivor Hernes, Monika Kvassheim, et al.Pageof 1